Phase Ⅰa Clinical Trial of a Pneumococcal Vaccine

Clinical trial NCT04087460 · COMPLETED

Trial details

NCT number: NCT04087460
Sponsor: CanSino Biologics Inc.
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Pneumonia Respiratory Tract Diseases Respiratory Tract Infections

Start date: 2020-04-10
Primary completion: 2021-05-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.